DOCS:NYSEDoximity, Inc. Analysis
Data as of 2026-08-31 - not real-time
$26.01
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Doximity, Inc. is neutral at $26.01, with no clear ordering between short and long averages. Across the trailing 30 sessions it gained 19.7%. With RSI at 58.2 the momentum picture is neutral, alongside a bearish MACD signal. Price has been bracketed by support at $19.88 and resistance at $40.00.
Valuation screens as fair: a P/E of 31.0 sits in line with the sector average of 30.2. Sell-side targets cluster 14.5% above the current quote. Revenue is growing at 7.3% on a 25.5% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 96.7%, a beta of 0.63 and a maximum drawdown of 76.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Valuation screens as fair: a P/E of 31.0 sits in line with the sector average of 30.2. Sell-side targets cluster 14.5% above the current quote. Revenue is growing at 7.3% on a 25.5% profit margin.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 96.7%, a beta of 0.63 and a maximum drawdown of 76.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Medical professional network Doximity NYSE:DOCS reported Q2 CY2026 results , with sales up 7.Medical professional network Doximity NYSE:DOCS reported Q2 CY2026 results exceeding the market’s revenue...Looking back on vertical software stocks’ Q1 earnings, we examine this quarter’s best and worst performers,...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 29.32
- MACD momentum is negative
- 30-day price change of +19.7%
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 31.0 versus sector average of 30.2
- Trading below the 200-day average of 29.32
- Analyst targets imply +14.5% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 31.0 versus sector average of 30.2
- Analyst targets imply +14.5% versus the current price
- Profit margin of 25.5% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin25.48%
P/E Ratio31.0
ROE17.21%
ROA10.95%
Debt/Equity1.06
P/B Ratio5.1
Op. Cash Flow$306.3M
Free Cash Flow$239.7M
Industry P/E30.2
Technical Analysis
TrendNeutral
RSI58.2
Support$19.88
Resistance$40.00
MA 20$24.96
MA 50$22.79
MA 200$29.32
MACDBearish
VolumeDecreasing
Fear & Greed Index94.21
Valuation
Fair Value$27.34
Target Price$29.78
Upside/Downside14.49%
GradeFair
TypeGrowth
Risk Assessment
Beta0.63
Volatility96.70%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.